pneumonia%20-%20community-acquired%20(pediatric)
PNEUMONIA - COMMUNITY-ACQUIRED (PEDIATRIC)
Community-acquired pneumonia is the presence of signs and symptoms of lower respiratory tract infection acquired outside of the hospital.
The most common bacterial cause of childhood pneumonia is Streptococcus pneumoniae. It usually causes about 1/3 of radiographically-confirmed pneumonia in children <2 years of age.
Viruses commonly affect children <1 year of age than those aged >2 years, respiratory syncytial viruses (RSV) being the most frequently detected virus.
Mixed infection may occur in 8-40% of community-acquired pneumonia cases.

Pneumonia%20-%20community-acquired%20(pediatric) Signs and Symptoms

Introduction

  • A previously healthy child presenting with signs and symptoms of lower respiratory tract infection, acquired outside of the hospital

Etiology

  • The most common bacterial cause of childhood pneumonia is Streptococcus pneumoniae
    • Usually causes about 1/3 of radiographically-confirmed pneumonia in children <2 years of age
    • Pneumonia secondary to group A streptococcus and Staphylococcus aureus is more frequently associated with empyema or pediatric intensive care unit (PICU) admission
  • Viruses commonly affect children <1 year of age than those aged >2 years; respiratory syncytial viruses (RSV) being the most frequently detected virus
    • Adenoviruses, bocavirus, human metapneumovirus, influenza A and B viruses, parainfluenza viruses, coronaviruses and rhinovirus are less frequently identified
  • Mixed infection may occur in 8-40% of community-acquired pneumonia (CAP) cases
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
3 days ago
Chest pain appears to be the principal complaint of patients hospitalized with a first myocardial infarction (MI), particularly among those in the youngest age group, a study has found.
Jairia Dela Cruz, 16 Sep 2020
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, 3 days ago
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
4 days ago
Women with pre-eclampsia are at higher risk of developing heart failure, a study suggests.